Effectiveness of medical taping concept in primary dysmenorrhoea: a two-armed randomized trial.

Effectiveness of medical taping concept in primary dysmenorrhoea: a two-armed randomized trial.
复制标题

DOI:
10.1038/srep16671
复制
发表时间:
2015-11-13
期刊:
影响因子:
4.6
通讯作者:
Gil-Guillén VF
Gil-Guillén VF
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Tomás-Rodríguez MI;Palazón-Bru A;Martínez-St John DRJ;Toledo-Marhuenda JV;Asensio-García MDR;Gil-Guillén VF

文献摘要

被引文献

相似文献

2014年,我们通过一项单盲、双臂临床试验(NCT02114723,ClinicalTrials.gov)对129名18-30岁患有原发性痛经(PD)的西班牙女性进行了4个月经周期(干预前:2个月;干预后:2个月)的跟踪调查,以评估MTC在原发性痛经(PD)中的有效性。我们有两组:干预组(75例),MTC覆盖T-11和T-12皮肤处;对照组(54例),另一组在两个大转子区域。我们的主要结果是:干预前和干预后2 小时后测量的疼痛差增加(2-h疼痛-0-h疼痛);干预后与干预前服药数量的差异;以及干预后的相关症状(疲劳、呕吐、腹泻、恶心等)。疼痛评估包括:腹部、腿部、头部和下背部。我们发现在片剂数量、腹痛和腿痛方面有显著差异(p < 0.05)。总而言之,在未开始药物治疗时,干预组的腹部和腿部疼痛较少。此外,干预导致了较低的片剂摄入量。然而,需要更多的研究来证实我们的结果,并分析如果女性在整个月经期不服用任何药片,MTC的有效性。
In 2014, we assessed the effectiveness of Medical Taping Concept (MTC) in Primary Dysmenorrhoea (PD) with a single-blind, two-armed clinical trial (NCT02114723, ClinicalTrials.gov) with a follow-up of 4 menstrual cycles (pre-intervention: 2 months; post-intervention: 2 months) in a sample formed by 129 Spanish women aged 18–30 years with PD. We had two groups: intervention group (75), MTC covering T-11 and T-12 dermatomes; control group (54), another taping in both greater trochanter areas. Our main outcome measures were: pre-intervention and post-intervention increase in pain difference measured 2 hours after commencement (2-h pain — 0-h pain); difference between the number of tablets ingested post-intervention and pre-intervention; and associated symptoms in post-intervention (fatigue, vomiting, diarrhoea, nausea and others). Pain was assessed in: abdomen, legs, head and lower back. We found significant differences (p < 0.05) for number of tablets, abdominal and leg pain. In conclusion, the intervention group had less abdominal and leg pain when pharmacological therapy was not started. Furthermore, the intervention resulted in a lower intake of tablets. Nevertheless, more studies are needed to corroborate our results and to analyze the MTC effectiveness if women do not take any tablets during the entire menstrual period.